Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-03-19

Clinical Trial Update: Abemaciclib in Combination With Androgen Deprivation Therapy for Locally Advanced Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating Abemaciclib with androgen deprivation therapy for locally advanced prostate cancer; the study was terminated and results have be…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Abemaciclib (abemaciclib)

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Prostate Cancer | Phase 2 | Status: TERMINATED | Results posted: 2025-03-19